(Q40081464)

17 September 2017

Bupropion hydrochloride versus placebo, in combination with cognitive behavioral therapy, for the treatment of cocaine abuse/dependence (English)

1 reference

cognitive behavioral therapy

17 September 2017

0 references

1 reference

Erin Rotheram-Fuller

3

0 references

author name string

Steve Shoptaw

1

1 reference

17 September 2017

Keith G Heinzerling

2

1 reference

17 September 2017

Uyen H Kao

4

1 reference

17 September 2017

Pin-Chieh Wang

5

1 reference

17 September 2017

Michelle A Bholat

6

1 reference

17 September 2017

Walter Ling

7

1 reference

17 September 2017

1 January 2008

1 reference

Journal of Addictive Diseases

17 September 2017

1 reference

17 September 2017

27

1 reference

17 September 2017

1

1 reference

17 September 2017

13-23

1 reference

Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study

17 September 2017

1 reference

https://api.crossref.org/works/10.1300%2FJ069V27N01_02

Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V27N01_02

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V27N01_02

Relationship between subjective effects of cocaine and dopamine transporter occupancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V27N01_02

The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V27N01_02

Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V27N01_02

New concepts in cocaine addiction: the dopamine depletion hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V27N01_02

Decreasing striatal 6-FDOPA uptake with increasing duration of cocaine withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V27N01_02

Association of cocaine withdrawal symptoms with more severe dependence and enhanced subjective response to cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V27N01_02

Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V27N01_02

Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V27N01_02

A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V27N01_02

A screening trial of amantadine as a medication for cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V27N01_02

Bromocriptine treatment for cocaine addiction: association with plasma prolactin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V27N01_02

A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V27N01_02

In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V27N01_02

Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V27N01_02

Bupropion occupancy of the dopamine transporter is low during clinical treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V27N01_02

A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V27N01_02

A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V27N01_02

Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V27N01_02

An intensive outpatient approach for cocaine abuse treatment. The Matrix model

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V27N01_02

The Fifth Edition of the Addiction Severity Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V27N01_02

Reliability and validity of the Cocaine Selective Severity Assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V27N01_02

Bupropion versus selective serotonin-reuptake inhibitors for treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V27N01_02

A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V27N01_02

21 January 2018

Identifiers

DOI

10.1300/J069V27N01_02

1 reference

17 September 2017

1 reference